Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma
Tongji Hospital
Tongji Hospital
Hebei Medical University Fourth Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing Friendship Hospital
Guangzhou University of Traditional Chinese Medicine
Shanghai Zhongshan Hospital
Alliance for Clinical Trials in Oncology
Sun Yat-sen University
West China Hospital
Sichuan University
First Affiliated Hospital of Wenzhou Medical University
Sun Yat-sen University
The First Affiliated Hospital of Zhengzhou University
Trans Tasman Radiation Oncology Group
China Medical University, China
Zhejiang Cancer Hospital
Children's National Research Institute
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Fudan University
Sichuan University
IRCCS San Raffaele
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Peking University First Hospital
Shanghai Zhongshan Hospital
Tang-Du Hospital
Peking University Third Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The Central Hospital of Lishui City
Fudan University